BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$860M |
| 3 |
Apple
AAPL
|
+$839M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$830M |
| 5 |
GE Aerospace
GE
|
+$800M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$362M |
| 2 |
Tesla
TSLA
|
+$288M |
| 3 |
NVIDIA
NVDA
|
+$265M |
| 4 |
MetLife
MET
|
+$261M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Consumer Discretionary | 8.14% |
| 3 | Financials | 7.71% |
| 4 | Healthcare | 6.1% |
| 5 | Communication Services | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YRD
4676
Yiren Digital
YRD
$105M
| $10.1K | ﹤0.01% |
2,100
| – | – |
|
4677
Century Therapeutics
IPSC
$360M
| $9.89K | ﹤0.01% |
+9,792
| New | +$13.3K |
|
4678
Tenaya Therapeutics
TNYA
$169M
| $9.79K | ﹤0.01% |
+6,849
| New | +$15.4K |
|
|
AKYA
4679
DELISTED
Akoya BioSciences
AKYA
| $9.76K | ﹤0.01% |
+4,263
| New | +$11.3K |
|
4680
Ispire Technology
ISPR
$97.6M
| $9.65K | ﹤0.01% |
+1,918
| New | +$11.8K |
|
4681
Shattuck Labs
STTK
$748M
| $9.61K | ﹤0.01% |
+7,939
| New | +$9.84K |
|
4682
Lineage Cell Therapeutics
LCTX
$273M
| $9.6K | ﹤0.01% |
+19,099
| New | +$14K |
|
|
BCYC
4683
Bicycle Therapeutics
BCYC
$280M
| $9.52K | ﹤0.01% |
680
-118
| -15% | -$2.53K |
|
4684
Global X 1-3 Month T-Bill ETF
CLIP
$2.4B
| $9.51K | ﹤0.01% |
95
+1
| +1% | +$100 |
|
4685
Ramaco Resources Class B
METCB
$421M
| $9.32K | ﹤0.01% |
+994
| New | +$9.64K |
|
|
PARAA
4686
DELISTED
Paramount Global Class A
PARAA
| $9.3K | ﹤0.01% |
+417
| New | +$9.3K |
|
4687
Pyxis Oncology
PYXS
$207M
| $9.22K | ﹤0.01% |
+5,910
| New | +$17K |
|
|
ADAG
4688
Adagene
ADAG
$244M
| $9.16K | ﹤0.01% |
+4,700
| New | +$11.1K |
|
|
ORKA
4689
Oruka Therapeutics
ORKA
$6.98B
| $9.07K | ﹤0.01% |
+468
| New | +$11.4K |
|
4690
Metagenomi Therapeutics
MGX
$46.5M
| $9.04K | ﹤0.01% |
2,504
-10,295
| -80% | -$24.8K |
|
4691
PepGen
PEPG
$197M
| $9.04K | ﹤0.01% |
+2,384
| New | +$14.9K |
|
|
HLVX
4692
DELISTED
HilleVax
HLVX
| $9.03K | ﹤0.01% |
+4,363
| New | +$8.19K |
|
4693
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$458M
| $9.02K | ﹤0.01% |
326
+324
| +16,200% | +$8.97K |
|
4694
Sagimet Biosciences
SGMT
$577M
| $8.9K | ﹤0.01% |
+1,977
| New | +$10K |
|
4695
The ONE Group
STKS
$56.5M
| $8.87K | ﹤0.01% |
3,058
-7,297
| -70% | -$24.2K |
|
4696
Black Diamond Therapeutics
BDTX
$118M
| $8.8K | ﹤0.01% |
+4,113
| New | +$11.8K |
|
4697
a.k.a. Brands
AKA
$118M
| $8.78K | ﹤0.01% |
469
-34
| -7% | -$743 |
|
4698
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.29B
| $8.67K | ﹤0.01% |
476
-3,830
| -89% | -$69.9K |
|
4699
First United
FUNC
$295M
| $8.63K | ﹤0.01% |
+256
| New | +$8.51K |
|
4700
Scilex Holding
SCLX
$48.4M
| $8.62K | ﹤0.01% |
+577
| New | +$14.7K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2024 Portfolio in Review
As of Q4 2024, BNP Paribas Financial Markets held 5,601 positions worth $178B, up 20% from $149B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets deployed $23.8B of net new capital in Q4 2024, opening 1,444 new positions and adding to 1,732 existing holdings. Its largest new stake was GE Aerospace: 4,486,125 shares worth $748M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Utilities Select Sector SPDR ETF, an estimated $362M trimmed.
- BNP Paribas Financial Markets's largest Q4 2024 buy was GE Aerospace: 4,486,125 shares worth $748M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $1.7B increase.
- BNP Paribas Financial Markets's biggest Q4 2024 reduction was State Street Utilities Select Sector SPDR ETF, cutting an estimated $362M.
- BNP Paribas Financial Markets fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q4 2024, selling an estimated $34M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $178B portfolio in Q4 2024.
- BNP Paribas Financial Markets opened 1,444 new positions and closed 206 in Q4 2024.
- BNP Paribas Financial Markets's portfolio value rose 20% quarter-over-quarter to $178B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2024, filed 14 Feb 2025.